
MHRA: FDA’s Transitional Enforcement Policy for Ethylene Oxide Sterilization Facility Changes for Class III Devices
On November 26, 2024, the FDA published guidance on its transitional enforcement policy for changes in ethylene oxide (EtO) sterilization facilities for Class III medical devices. The policy aims to prevent potential disruptions in the supply chain of sterile medical devices while sterilization facilities adapt to updated Environmental Protection Agency (EPA) requirements.